Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 333

1.

Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.

Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.

Int J Pharm. 2008 Apr 16;354(1-2):235-41. doi: 10.1016/j.ijpharm.2007.11.027. Epub 2007 Nov 22.

PMID:
18182259
2.
3.

Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.

Jain S, Singh P, Mishra V, Vyas SP.

Immunol Lett. 2005 Oct 15;101(1):41-9. Epub 2005 Apr 25.

PMID:
15869802
4.

Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.

Raghuwanshi D, Mishra V, Das D, Kaur K, Suresh MR.

Mol Pharm. 2012 Apr 2;9(4):946-56. doi: 10.1021/mp200553x. Epub 2012 Mar 20.

5.

Cationic transfersomes based topical genetic vaccine against hepatitis B.

Mahor S, Rawat A, Dubey PK, Gupta PN, Khatri K, Goyal AK, Vyas SP.

Int J Pharm. 2007 Aug 1;340(1-2):13-9. Epub 2007 Mar 12.

PMID:
17446015
6.

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.

Eur J Pharm Biopharm. 2008 Jun;69(2):405-16. doi: 10.1016/j.ejpb.2008.01.019. Epub 2008 Jan 31.

PMID:
18364251
7.

Surface modified liposomes for nasal delivery of DNA vaccine.

Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP.

Vaccine. 2008 Apr 24;26(18):2225-33. doi: 10.1016/j.vaccine.2008.02.058. Epub 2008 Mar 17.

PMID:
18396362
8.

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ.

Eur J Pharm Biopharm. 2004 Jan;57(1):123-31.

PMID:
14729088
9.

Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).

Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP.

J Pharm Pharm Sci. 2008;11(1):59-66.

10.

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.

Gupta NK, Tomar P, Sharma V, Dixit VK.

Vaccine. 2011 Nov 8;29(48):9026-37. doi: 10.1016/j.vaccine.2011.09.033. Epub 2011 Sep 20.

PMID:
21939718
11.

Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.

Pandey RS, Dixit VK.

J Drug Target. 2010 May;18(4):282-91. doi: 10.3109/10611860903450015.

PMID:
19958131
12.

Chitosan-based nanoparticles for improving immunization against hepatitis B infection.

Prego C, Paolicelli P, Díaz B, Vicente S, Sánchez A, González-Fernández A, Alonso MJ.

Vaccine. 2010 Mar 19;28(14):2607-14. doi: 10.1016/j.vaccine.2010.01.011. Epub 2010 Jan 20.

PMID:
20096389
13.

Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.

Dutta T, Garg M, Jain NK.

Vaccine. 2008 Jun 25;26(27-28):3389-94. doi: 10.1016/j.vaccine.2008.04.058. Epub 2008 May 12.

PMID:
18511160
14.

M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.

Gupta PN, Khatri K, Goyal AK, Mishra N, Vyas SP.

J Drug Target. 2007 Dec;15(10):701-13.

PMID:
18041638
15.

Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.

Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.

J Virol Methods. 2008 Nov;153(2):142-8. doi: 10.1016/j.jviromet.2008.07.013. Epub 2008 Sep 3.

PMID:
18722475
16.

Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.

Jiang L, Qian F, He X, Wang F, Ren D, He Y, Li K, Sun S, Yin C.

J Gene Med. 2007 Apr;9(4):253-64.

PMID:
17397104
17.

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.

Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.

PMID:
18662762
18.

Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.

Yuan X, Yang X, Cai D, Mao D, Wu J, Zong L, Liu J.

Vaccine. 2008 Jul 4;26(29-30):3727-34. doi: 10.1016/j.vaccine.2008.04.065. Epub 2008 May 16.

PMID:
18524427
19.

Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes.

Chen L, Zhu J, Li Y, Lu J, Gao L, Xu H, Fan M, Yang X.

PLoS One. 2013 Aug 20;8(8):e71953. doi: 10.1371/journal.pone.0071953. eCollection 2013.

20.
Items per page

Supplemental Content

Write to the Help Desk